Literature DB >> 28236226

NMR resonance assignments of the FKBP domain of human aryl hydrocarbon receptor-interacting protein-like 1 (AIPL1) in complex with a farnesyl ligand.

Liping Yu1,2, Ravi P Yadav3, Nikolai O Artemyev4,5.   

Abstract

Aryl hydrocarbon receptor-interacting protein-like 1 (AIPL1) is a specialized chaperone of phosphodiesterase 6, a key effector enzyme in the phototransduction cascade. The FKBP domain of AIPL1 is known to bind the farnesyl moiety of PDE6. Mutations in AIPL1, including many missense mutations in the FKBP domain, have been associated with Leber congenital amaurosis, a severe blinding disease. Here, we report the backbone and sidechain assignments of the N-terminal FKBPΔloop (with a loop deletion) of AIPL1 in complex with a farnesyl ligand. We also compare the predicted secondary structures of FKBPΔloop with those of a highly homologous AIP FKBP. These results show that the FKBP domains of AIP and AIPL1 have similar folds, but display subtle differences in structure and dynamics. Therefore, these assignments provide a framework for further elucidation of the mechanism of farnesyl binding and the function of AIPL1 FKBP.

Entities:  

Keywords:  AIP; AIPL1; Chaperone; FKBP; Phosphodiesterase 6

Mesh:

Substances:

Year:  2017        PMID: 28236226      PMCID: PMC5385707          DOI: 10.1007/s12104-017-9730-2

Source DB:  PubMed          Journal:  Biomol NMR Assign        ISSN: 1874-270X            Impact factor:   0.746


  23 in total

1.  NMR assignments of the FKBP-type PPIase domain of the human aryl-hydrocarbon receptor-interacting protein (AIP).

Authors:  Miriam Linnert; Katja Haupt; Yi-Jan Lin; Sandra Kissing; Anne-Katrin Paschke; Gunter Fischer; Matthias Weiwad; Christian Lücke
Journal:  Biomol NMR Assign       Date:  2012-10       Impact factor: 0.746

2.  NMR View: A computer program for the visualization and analysis of NMR data.

Authors:  B A Johnson; R A Blevins
Journal:  J Biomol NMR       Date:  1994-09       Impact factor: 2.835

3.  NMRPipe: a multidimensional spectral processing system based on UNIX pipes.

Authors:  F Delaglio; S Grzesiek; G W Vuister; G Zhu; J Pfeifer; A Bax
Journal:  J Biomol NMR       Date:  1995-11       Impact factor: 2.835

Review 4.  Multidimensional heteronuclear nuclear magnetic resonance of proteins.

Authors:  G M Clore; A M Gronenborn
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

5.  The FKBP-type domain of the human aryl hydrocarbon receptor-interacting protein reveals an unusual Hsp90 interaction.

Authors:  Miriam Linnert; Yi-Jan Lin; Annika Manns; Katja Haupt; Anne-Katrin Paschke; Gunter Fischer; Matthias Weiwad; Christian Lücke
Journal:  Biochemistry       Date:  2013-03-13       Impact factor: 3.162

Review 6.  AIP and its interacting partners.

Authors:  Giampaolo Trivellin; Márta Korbonits
Journal:  J Endocrinol       Date:  2011-03-31       Impact factor: 4.286

7.  The Leber congenital amaurosis gene product AIPL1 is localized exclusively in rod photoreceptors of the adult human retina.

Authors:  Jacqueline van der Spuy; J Paul Chapple; Brian J Clark; Philip J Luthert; Charanjit S Sethi; Michael E Cheetham
Journal:  Hum Mol Genet       Date:  2002-04-01       Impact factor: 6.150

8.  The phenotype of Leber congenital amaurosis in patients with AIPL1 mutations.

Authors:  Sharola Dharmaraj; Bart P Leroy; Melanie M Sohocki; Robert K Koenekoop; Isabelle Perrault; Khalid Anwar; Shagufta Khaliq; R Summathi Devi; David G Birch; Elaine De Pool; Natalio Izquierdo; Lionel Van Maldergem; Mohammad Ismail; Annette M Payne; Graham E Holder; Shomi S Bhattacharya; Alan C Bird; Josseline Kaplan; Irene H Maumenee
Journal:  Arch Ophthalmol       Date:  2004-07

9.  Aryl Hydrocarbon Receptor-interacting Protein-like 1 Is an Obligate Chaperone of Phosphodiesterase 6 and Is Assisted by the γ-Subunit of Its Client.

Authors:  Kota N Gopalakrishna; Kimberly Boyd; Ravi P Yadav; Nikolai O Artemyev
Journal:  J Biol Chem       Date:  2016-06-07       Impact factor: 5.157

10.  Interaction of aryl hydrocarbon receptor-interacting protein-like 1 with the farnesyl moiety.

Authors:  Anurima Majumder; Kota N Gopalakrishna; Pallavi Cheguru; Lokesh Gakhar; Nikolai O Artemyev
Journal:  J Biol Chem       Date:  2013-06-04       Impact factor: 5.157

View more
  6 in total

1.  Unique structural features of the AIPL1-FKBP domain that support prenyl lipid binding and underlie protein malfunction in blindness.

Authors:  Ravi P Yadav; Lokesh Gakhar; Liping Yu; Nikolai O Artemyev
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-24       Impact factor: 11.205

2.  Interaction of the tetratricopeptide repeat domain of aryl hydrocarbon receptor-interacting protein-like 1 with the regulatory Pγ subunit of phosphodiesterase 6.

Authors:  Ravi P Yadav; Kimberly Boyd; Liping Yu; Nikolai O Artemyev
Journal:  J Biol Chem       Date:  2019-09-05       Impact factor: 5.157

Review 3.  AIPL1: A specialized chaperone for the phototransduction effector.

Authors:  Ravi P Yadav; Nikolai O Artemyev
Journal:  Cell Signal       Date:  2017-09-20       Impact factor: 4.315

4.  Clinical and functional analyses of AIPL1 variants reveal mechanisms of pathogenicity linked to different forms of retinal degeneration.

Authors:  Almudena Sacristan-Reviriego; Hoang Mai Le; Michalis Georgiou; Isabelle Meunier; Beatrice Bocquet; Anne-Françoise Roux; Chrisostomos Prodromou; James Bainbridge; Michel Michaelides; Jacqueline van der Spuy
Journal:  Sci Rep       Date:  2020-10-16       Impact factor: 4.379

Review 5.  The Role of Hsp90 in Retinal Proteostasis and Disease.

Authors:  Kalliopi Ziaka; Jacqueline van der Spuy
Journal:  Biomolecules       Date:  2022-07-12

6.  The integrity and organization of the human AIPL1 functional domains is critical for its role as a HSP90-dependent co-chaperone for rod PDE6.

Authors:  Almudena Sacristan-Reviriego; James Bellingham; Chrisostomos Prodromou; Annika N Boehm; Neruban Kumaran; James Bainbridge; Michel Michaelides; Jacqueline van der Spuy
Journal:  Hum Mol Genet       Date:  2017-11-15       Impact factor: 6.150

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.